Patents by Inventor Timothy E. O'Neill

Timothy E. O'Neill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stabilization of Therapeutic Agents to Facilitate Administration
    Publication number: 20180043032
    Abstract: The present invention provides for a carrier complex for administration of therapeutic agents. In one aspect, an isolated C. botulinum carrier complex is provided, where the carrier complex lacks a native neurotoxin subunit.
    Type: Application
    Filed: October 9, 2017
    Publication date: February 15, 2018
    Inventors: Jennifer L. Ton, Ronald C. Bates, Ji Zheng, Phillip P. Nguyen, Timothy E. O'Neill
  • Stabilization of therapeutic agents to facilitate administration
    Patent number: 9782492
    Abstract: The present invention provides for a carrier complex for administration of therapeutic agents. In one aspect, an isolated C. botulinum carrier complex is provided, where the carrier complex lacks a native neurotoxin subunit.
    Type: Grant
    Filed: February 19, 2016
    Date of Patent: October 10, 2017
    Assignee: Allergan, Inc.
    Inventors: Jennifer L. Ton, Ronald C. Bates, Ji Zheng, Phillip P. Nguyen, Timothy E. O'Neill
  • Stabilization of Therapeutic Agents to Facilitate Administration
    Publication number: 20160166707
    Abstract: The present invention provides for a carrier complex for administration of therapeutic agents. In one aspect, an isolated C. botulinum carrier complex is provided, where the carrier complex lacks a native neurotoxin subunit.
    Type: Application
    Filed: February 19, 2016
    Publication date: June 16, 2016
    Inventors: Jennifer L. Ton, Ronald C. Bates, Ji Zheng, Phillip P. Nguyen, Timothy E. O'Neill
  • Stabilization of Therapeutic Agents to Facilitate Administration
    Publication number: 20130085267
    Abstract: The present invention provides for a carrier complex for administration of therapeutic agents. In one aspect, an isolated C. botulinum carrier complex is provided, where the carrier complex lacks a native neurotoxin subunit.
    Type: Application
    Filed: December 15, 2010
    Publication date: April 4, 2013
    Applicant: ALLERGAN, INC.
    Inventors: Jennifer L. Ton, Ronald C. Bates, Ji Zheng, Phillip P. Nguyen, Timothy E. O'Neill